Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This is randomized, multicentre study aimed to compare a standard maintenance therapy with
Interferon-Dexamethasone with an experimental therapy based on Thalidomide-Dexamethasone in
patients with multiple myeloma who responded to ThaDD induction therapy